Europe has launched a major initiative known as CHAIN to accelerate the clinical adoption of artificial intelligence in cardiovascular care across 13 countries. Aligned with regional regulatory frameworks, the project aims to bridge the gap between algorithmic innovation and everyday hospital practice.
CHAIN Framework Introduces AI Passports for Heart Disease Treatment
- What is happening: A centralized framework called CHAIN is being rolled out to evaluate and integrate artificial intelligence software into heart disease treatment.
- Why it matters: This initiative creates standardized “AI Passports” to prove which diagnostic and treatment tools actually work safely in real-world hospitals.
- How patients are affected: Over the next three years, participating hospitals will deploy these validated tools to improve early detection, preventative care, and the management of complex heart conditions.
CHAIN Integrates with EU Regulatory Frameworks and Research Projects
The rollout of CHAIN arrives as regional authorities reshape how AI is developed, evaluated, and deployed. The initiative intersects directly with the European Health Data Space, the AI Act, and evolving EU regulatory frameworks for medical products, including pharmaceutical, medical devices and in vitro diagnostic legislation.
Rather than operating in isolation, CHAIN will build upon existing EU health research frameworks. These synergies include major collaborative projects such as EUCAIM, COMPASS AI, AI4HF, DataTools4Heart, EHDEN, JACARDI, TEHDAS2, and Xt-EHR. By connecting these digital health ecosystems, the project seeks to maximize complementarities and impact.
To establish clinical confidence, validated algorithms will be distributed through a centralized European repository. Each tool will carry an AI Passport documenting its specific performance, safety, and suitability for clinical use. These credentials provide hospitals, healthcare authorities and professionals with transparent evidence regarding which software solutions function reliably.
Real-World Deployment Across Thirteen Countries
To move beyond theoretical modeling, the initiative will implement six distinct real-world use cases across 13 countries. These pilot deployments target four core pillars of cardiology: prevention, early detection, clinical decision support, and the management of complex cardiovascular conditions.
Olivér Várhelyi, EU Commissioner for Health and Animal Welfare, emphasized the practical shift in focus. The question is no longer simply what AI can do. The question is how we make it work safely and effectively for patients and health professionals in everyday healthcare. This is where CHAIN can make a real difference,
Várhelyi stated regarding the initiative.
| Initiative Pillar | Operational Focus | Target Impact |
|---|---|---|
| Prevention | Risk stratification algorithms | Early identification of asymptomatic populations |
| Early Detection | Imaging and biomarker analysis | Faster, more accurate diagnostic triage |
| Decision Support | Automated treatment pathway matching | Reduced clinical burden and protocol adherence |
| Complex Care | Longitudinal disease monitoring | Personalized management of advanced pathologies |
Consortium Creates Strategic Roadmap for Scaling AI in Cardiology
The multi-year project is structured around a defined timeline. Over the next three years, the consortium intends to finalize a standardized strategic roadmap for scaling AI adoption in cardiology throughout Europe.
Professor Asselbergs, speaking on the long-term goals of the consortium, noted the broader utility for research and industry. Over the next three years, we hope to create a strategic roadmap for scaling AI adoption in cardiology across Europe. The infrastructure and standards will benefit research and industry, and the validated decision-support tools will help reduce the burden on healthcare systems. Ultimately, the availability of trustworthy tools should translate into earlier, more accurate diagnosis and safer, personalised care for patients,
Asselbergs concluded.
The resulting infrastructure is designed to support both academic investigators and commercial developers by providing clear compliance benchmarks.
References
- European Society of Cardiology. Initiative to accelerate AI uptake in cardiovascular care.
- European Commission. Artificial Intelligence Act and European Health Data Space regulatory frameworks.
